WAT: Rasio kapitalisasi marang pendapatan Waters Corp

Waters Corporation leads the development of precision systems for biopharma, leveraging its robust R&D potential. The price-to-sales ratio price action on the GURU.Markets chart shows that the 8.10 mark indicates the asset's valuation level. However, geopolitical fragmentation is hindering equipment exports. Stable revenue from consumables protects the company's position, ensuring resilience against market peers.

Waters (WAT): Multiplikator P/S saka 04.07.2022 nganti 13.11.2026

Rincian metrik lan analitis perusahaan Waters Corp. (WAT)

- kuotasi saiki lan rata-rata prakiraan nilai:

Rega bursa waters.com|WAT - Prakiraan konsensus analis

- informasi kapitalisasi pasar:

Kapitalisasi pasar Waters Corp.|WAT - Nilai Perusahaan

- rincian valuasi buku bisnis:

Aset Bersih saben Saham Waters|WAT - Kapitalisasi Buku|Rasio Kapitalisasi marang Aset Bersih waters.com|WAT - Total Aset Perusahaan

- statistik kawajiban utang lan likuiditas:

- data bathi resik lan rasio valuasi:

WAT - Penghasilan resik|Proyeksi bathi mangsa ngarep Waters Corporation|WAT - Pangali P/E|Kapitalisasi marang proyeksi bathi Waters Corp|WAT - Rasio rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi operasional sadurunge panyusutan Waters Corp.|WAT - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Waters|WAT - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan waters.com|WAT - Wutah bathi saben saham ing taun lumaku|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep Waters Corporation

- rincian pendapatan lan dodolan emiten:

WAT - Dodolan perusahaan|Prakiraan volume pendapatan perusahaan waters.com|WAT - Kapitalisasi marang pendapatan|Multiplikator forward rega marang pendapatan Waters Corp.

Ringkesan analitik perusahaan:waters.com, WAT

Scaling the automation of chromatograph assembly and implementing software robots for instrument calibration directly impact the operating revenue of Waters Corporation (WAT). By analyzing the price-to-sales ratio, an investor compares market capitalization with actual cash flow from sales, which allows for an assessment of the asset's premium and confirms the fundamental stability of the business through the lens of its yield.

Perusahaan pesaing

ABT - Rega marang dodolan|Multiplikator P/S TMO (Thermo Fisher)|GEHC: Rasio kapitalisasi marang pendapatan|Mettler-Toledo International Inc. - Multiplikator P/S|Koefisien rega marang pendapatan Bio-Techne Inc. TECH|BRKR: Multiplikator P/S|Kapitalisasi marang pendapatan azenta.com|VREX (Varex Imaging Corporation) - Multiplikator P/S|Multiplikator P/S Semler Scientific Inc|Rasio rega marang pendapatan Butterfly iQ (BFLY)|Rasio rega marang pendapatan MLAB (Mesa Laboratories Corp.)|Quantum-Si - Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan NNOX|Quanterix - Multiplikator P/S|Rega marang dodolan 908 Devices Inc|capsovision.com (CV) - Rasio rega marang pendapatan|Multiplikator rega marang pendapatan MaxCyte Inc MXCT|Kapitalisasi marang pendapatan RPID|Multiplikator P/S seer.bio|Multiplikator P/S HYPR|Koefisien rega marang pendapatan FONAR Corp.|Rasio rega marang pendapatan Daxor DXR|MDAI (spectral-ai.com) - Rasio rega marang dodolan|VIVS - Rasio rega marang pendapatan|aclarion.com (ACON) - Kapitalisasi marang pendapatan|AKYA: Multiplikator P/S|Rega marang dodolan ThermoGenesis Holdings, Inc. (THMO)|Rasio rega marang pendapatan Talis Biomedical Corp.|Rasio kapitalisasi marang pendapatan TTOO (T2 Biosystems Inc)